Login / Signup

Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey.

Daisy S MasseyYuntian LiuAnia M JastreboffRohan KheraChima D NdumeleFatima RodriguezKarol E WatsonHarlan M Krumholz
Published in: Circulation. Cardiovascular quality and outcomes (2023)
Keyphrases
  • study protocol
  • phase ii
  • randomized controlled trial
  • mesenchymal stem cells
  • smoking cessation
  • replacement therapy